InvestorsHub Logo
Followers 74
Posts 3647
Boards Moderated 0
Alias Born 03/23/2013

Re: None

Thursday, 08/04/2022 2:22:53 PM

Thursday, August 04, 2022 2:22:53 PM

Post# of 429311
What all malignant neoplasms have in common is their need for vascularization in order to grow.

This trial using EPA to treat prostate cancer patients showed a significant reduction in tumor vascularity. It is likely, the same response would be expected in most varying types of malignancies.

Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity

If V can be shown to significantly reduce tumor (most tumors) vascularity to arrest spread, then suddenly the drug becomes an efficacious agent to treat and prevent cancer and cardiac victims (2 leading causes of death).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News